HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Plasma cell-free DNA variant analysis compared with methylated DNA analysis in renal cell carcinoma.

AbstractPURPOSE:
Plasma cell-free DNA (cfDNA) variant analysis is commonly used in many cancer subtypes. Cell-free methylated DNA immunoprecipitation sequencing (cfMeDIP-seq) has shown high sensitivity for cancer detection. To date, studies have not compared the sensitivity of both methods in a single cancer subtype.
METHODS:
cfDNA from 40 metastatic RCC (mRCC) patients was subjected to targeted panel variant analysis. For 34 of 40, cfMeDIP-seq was also performed. A separate cohort of 38 mRCC patients were used in cfMeDIP-seq analysis to train an RCC classifier.
RESULTS:
cfDNA variant analysis detected 21 candidate variants in 11 of 40 mRCC patients (28%), after exclusion of 2 germline variants and 6 variants reflecting clonal hematopoiesis. Among 23 patients with parallel tumor sequencing, cfDNA analysis alone identified variants in 9 patients (39%), while cfDNA analysis focused on tumor sequencing variant findings improved the sensitivity to 52%. In 34 mRCC patients undergoing cfMeDIP-seq, cfDNA variant analysis identified variants in 7 (21%), while cfMeDIP-seq detected all mRCC cases (100% sensitivity) with 88% specificity in 34 control subjects. In 5 patients with cfDNA variants and serial samples, variant frequency correlated with response to therapy.
CONCLUSION:
cfMeDIP-seq is significantly more sensitive for mRCC detection than cfDNA variant analysis. However, cfDNA variant analysis may be useful for monitoring response to therapy.
AuthorsKathryn Lasseter, Amin H Nassar, Lana Hamieh, Jacob E Berchuck, Pier Vitale Nuzzo, Keegan Korthauer, Atul B Shinagare, Barbara Ogorek, Rana McKay, Aaron R Thorner, Gwo-Shu Mary Lee, David A Braun, Rupal S Bhatt, Matthew Freedman, Toni K Choueiri, David J Kwiatkowski
JournalGenetics in medicine : official journal of the American College of Medical Genetics (Genet Med) Vol. 22 Issue 8 Pg. 1366-1373 (08 2020) ISSN: 1530-0366 [Electronic] United States
PMID32341571 (Publication Type: Journal Article)
Chemical References
  • Biomarkers, Tumor
  • Cell-Free Nucleic Acids
  • DNA
Topics
  • Biomarkers, Tumor (genetics)
  • Carcinoma, Renal Cell (diagnosis, genetics)
  • Cell-Free Nucleic Acids (genetics)
  • DNA
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Kidney Neoplasms (diagnosis, genetics)
  • Plasma

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: